| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-07 |
4 |
S |
$2.45 |
$7,350 |
I/I |
(3,000) |
736,258 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-06-09 |
4 |
B |
$14.17 |
$1,062,750 |
I/I |
75,000 |
736,994 |
2.25 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-04 |
4 |
S |
$2.53 |
$3,542 |
I/I |
(1,400) |
739,258 |
0 |
% |
|
| BIOL |
Biolase Inc |
|
• • • |
2020-02-11 |
4 |
S |
$0.60 |
$784,759 |
I/I |
(1,307,931) |
739,820 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-02 |
4 |
S |
$2.81 |
$8,430 |
I/I |
(3,000) |
740,658 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-01 |
4 |
S |
$2.97 |
$8,910 |
I/I |
(3,000) |
743,658 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-31 |
4 |
S |
$3.01 |
$29,652 |
I/I |
(9,851) |
746,658 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-17 |
4 |
B |
$1.94 |
$40,327 |
I/I |
20,769 |
751,931 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-18 |
4 |
B |
$1.96 |
$8,913 |
I/I |
4,548 |
756,479 |
1.5 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-28 |
4 |
S |
$3.01 |
$12,516 |
I/I |
(4,158) |
756,509 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-27 |
4 |
S |
$3.03 |
$12,120 |
I/I |
(4,000) |
760,667 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-26 |
4 |
S |
$3.03 |
$22,483 |
I/I |
(7,420) |
764,667 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-22 |
4 |
B |
$1.99 |
$21,517 |
I/I |
10,818 |
767,297 |
1.5 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-25 |
4 |
S |
$3.07 |
$9,643 |
I/I |
(3,141) |
772,087 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-23 |
4 |
B |
$2.03 |
$10,130 |
I/I |
5,000 |
772,297 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-25 |
4 |
B |
$1.99 |
$2,388 |
I/I |
1,200 |
773,497 |
1.42 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-24 |
4 |
S |
$3.06 |
$14,153 |
I/I |
(4,625) |
775,228 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-21 |
4 |
S |
$3.09 |
$62,844 |
I/I |
(20,338) |
779,853 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-26 |
4 |
B |
$1.97 |
$16,629 |
I/I |
8,448 |
781,945 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-05-01 |
4 |
B |
$1.96 |
$392 |
I/I |
200 |
782,145 |
1.42 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-05-02 |
4 |
B |
$1.98 |
$1,581 |
I/I |
800 |
782,945 |
1.42 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-05-07 |
4 |
B |
$1.99 |
$398 |
I/I |
200 |
783,145 |
1.42 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-05-09 |
4 |
B |
$2.00 |
$14,600 |
I/I |
7,300 |
790,445 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-05-10 |
4 |
B |
$2.00 |
$1,600 |
I/I |
800 |
791,245 |
1.42 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2020-08-26 |
4 |
B |
$4.25 |
$1,552,274 |
I/I |
365,241 |
793,635 |
1.5 |
% |
|
634 Records found
|
|
Page 7 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
